Jonas Bergh

Karolinska University Hospital

Sweden

Research Interests

Explore related searches

Professors in Sweden Professors in Cancer Biology Cancer Biology professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (15)

Michele Masucci

Karolinska Institutet

SWEDEN

View details

Andri Papakonstantinou

Vall d´Hebron Institut d´Oncologia

SPAIN

View details

Monika Ehnman

Karolinska Institutet

SWEDEN

View details

Jeremy Braybrooke

Honorary Associate Professor

University of Bristol

UNITED KINGDOM

View details

Georgios C. Manikis

Karolinska Institutet

SWEDEN

View details

Per Hall

University of Pennsylvania

SWEDEN

View details

Nikos Tsiknakis

Karolinska Institutet

SWEDEN

View details

John Crown

St. Vincent's University Hospital

IRELAND

View details

Andreas Lundqvist

Karolinska Institutet

SWEDEN

View details

Juan Rafael de la Haba Rodríguez

Profesor Titular

Universidad de Córdoba

SPAIN

View details

Theodoros Foukakis

Karolinska Institutet

SWEDEN

View details

Lucy Gettins

University of Oxford

UNITED KINGDOM

View details

Päivi Östling

Karolinska Institutet

SWEDEN

View details

Haomin Yang

Karolinska Institutet

SWEDEN

View details

Artur Mezheyeuski

Uppsala University

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jonas Bergh

Research Interests

Explore related searches

Contact this professor

Articles (10)

Dissecting Tumor-Immune Microenvironment in Breast Cancer at a Spatial and Multiplex Resolution

Risk of heart disease following treatment for breast cancer – results from a population-based cohort study

Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials

Author Correction: The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology

Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer

The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology

Women with short survival after diagnosis of metastatic breast cancer: a population-based registry study

A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapy.

A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer.

CD11c-CD8 Spatial Cross Presentation: A Novel Approach to Link Immune Surveillance and Patient Survival in Soft Tissue Sarcoma

Collaborators (15)

Michele Masucci

Andri Papakonstantinou

Monika Ehnman

Jeremy Braybrooke

Georgios C. Manikis

Per Hall

Nikos Tsiknakis

John Crown

Andreas Lundqvist

Juan Rafael de la Haba Rodríguez

Theodoros Foukakis

Lucy Gettins

Päivi Östling

Haomin Yang

Artur Mezheyeuski

Make your next move.